Complement Receptor Deficiency: Differential Diagnoses & Workup

References

1. Fairweather D, Frisancho-Kiss S, Njoku DB, Nyland JF, Kaya Z, Yusung SA, et al. Complement receptor 1 and 2 deficiency increases coxsackievirus B3-induced myocarditis, dilated cardiomyopathy, and heart failure by increasing macrophages, IL-1beta, and immune complex deposition in the heart. J Immunol. Mar 15 2006;176(6):3516-24. [Medline].

2. Jacobson AC, Weis JJ, Weis JH. Complement receptors 1 and 2 influence the immune environment in a B cell receptor-independent manner. J Immunol. Apr 1 2008;180(7):5057-66. [Medline].

3. Boos L, Campbell IL, Ames R, Wetsel RA, Barnum SR. Deletion of the complement anaphylatoxin C3a receptor attenuates, whereas ectopic expression of C3a in the brain exacerbates, experimental autoimmune encephalomyelitis. J Immunol. Oct 1 2004;173(7):4708-14. [Medline].

4. Tone Y, Wada T, Shibata F, Toma T, Hashida Y, Kasahara Y, et al. Somatic revertant mosaicism in a patient with leukocyte adhesion deficiency type 1. Blood. Feb 1 2007;109(3):1182-4. [Medline].

5. Fearon DT. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte. J Exp Med. Jul 1 1980;152(1):20-30. [Medline].

6. Bautsch W, Hoymann HG, Zhang Q, Meier-Wiedenbach I, Raschke U, Ames RS, et al. Cutting edge: guinea pigs with a natural C3a-receptor defect exhibit decreased bronchoconstriction in allergic airway disease: evidence for an involvement of the C3a anaphylatoxin in the pathogenesis of asthma. J Immunol. Nov 15 2000;165(10):5401-5. [Medline].

7. Anderson DC, Schmalstieg FC, Arnaout MA, Kohl S, Tosi MF, Dana N, et al. Abnormalities of polymorphonuclear leukocyte function associated with a heritable deficiency of high molecular weight surface glycoproteins (GP138): common relationship to diminished cell adherence. J Clin Invest. Aug 1984;74(2):536-51. [Medline].

8. Atkinson JP. Complement deficiency. Predisposing factor to autoimmune syndromes. Am J Med. Dec 23 1988;85(6A):45-7. [Medline].

9. Barrington RA, Zhang M, Zhong X, Jonsson H, Holodick N, Cherukuri A, et al. CD21/CD19 coreceptor signaling promotes B cell survival during primary immune responses. J Immunol. Sep 1 2005;175(5):2859-67. [Medline].

10. Bartholomew WR, Shanahan TC. Complement components and receptors: deficiencies and disease associations. Immunol Ser. 1990;52:33-51. [Medline].

11. Bowen TJ, Ochs HD, Altman LC, Price TH, Van Epps DE, Brautigan DL, et al. Severe recurrent bacterial infections associated with defective adherence and chemotaxis in two patients with neutrophils deficient in a cell-associated glycoprotein. J Pediatr. Dec 1982;101(6):932-40. [Medline].

12. Carroll MC. The role of complement in B cell activation and tolerance. Adv Immunol. 2000;74:61-88. [Medline].

13. Colten HR, Rosen FS. Complement deficiencies. Annu Rev Immunol. 1992;10:809-34. [Medline].

14. Davies KA. Complement. Baillieres Clin Haematol. Dec 1991;4(4):927-55. [Medline].

15. Fischer A, Seger R, Durandy A, Grospierre B, Virelizier JL, Le Deist F, et al. Deficiency of the adhesive protein complex lymphocyte function antigen 1, complement receptor type 3, glycoprotein p150,95 in a girl with recurrent bacterial infections. Effects on phagocytic cells and lymphocyte functions. J Clin Invest. Dec 1985;76(6):2385-92. [Medline].

16. Glovsky MM, Ward PA, Johnson KJ. Complement determinations in human disease. Ann Allergy Asthma Immunol. Dec 2004;93(6):513-22; quiz 523-5, 605. [Medline].

17. Haas KM, Tedder TF. Role of the CD19 and CD21/35 receptor complex in innate immunity, host defense and autoimmunity. Adv Exp Med Biol. 2005;560:125-39. [Medline].

18. Harlan JM. Leukocyte adhesion deficiency syndrome: insights into the molecular basis of leukocyte emigration. Clin Immunol Immunopathol. Jun 1993;67(3 Pt 2):S16-24. [Medline].

19. Holers VM. Phenotypes of complement knockouts. Immunopharmacology. Aug 2000;49(1-2):125-31. [Medline].

20. Kazatchkine MD, Fearon DT. Deficiencies of human C3 complement receptors type 1 (CR1, CD35) and type 2 (CR2, CD21). Immunodefic Rev. 1990;2(1):17-41. [Medline].

21. Kazatchkine MD, Jouvin MH, Wilson JG, Fischer E, Fischer A. Human diseases associated with C3 receptor deficiencies. Immunol Lett. Feb 1987;14(3):191-5. [Medline].

22. Kildsgaard J, Hollmann TJ, Matthews KW, Bian K, Murad F, Wetsel RA. Cutting edge: targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock. J Immunol. Nov 15 2000;165(10):5406-9. [Medline].

23. Kirschfink M. Controlling the complement system in inflammation. Immunopharmacology. Dec 1997;38(1-2):51-62. [Medline].

24. Köhl J, Gessner JE. On the role of complement and Fc gamma-receptors in the Arthus reaction. Mol Immunol. Sep-Oct 1999;36(13-14):893-903. [Medline].

25. Morgan BP, Daha M, Meri S, Nicholson-Weller A. Into the third century of complement research. Immunol Today. Dec 2000;21(12):603-5. [Medline].

26. Moulds JM, Krych M, Holers VM, Liszewski MK, Atkinson JP. Genetics of the complement system and rheumatic diseases. Rheum Dis Clin North Am. Nov 1992;18(4):893-914. [Medline].

27. Nielsen CH, Fischer EM, Leslie RG. The role of complement in the acquired immune response. Immunology. May 2000;100(1):4-12. [Medline].

28. Nybo M, Sørensen O, Leslie R, Wang P. Reduced expression of C5a receptors on neutrophils from cord blood. Arch Dis Child Fetal Neonatal Ed. Mar 1998;78(2):F129-32. [Medline].

29. Perlmutter DH, Colten HR. Molecular basis of complement deficiencies. Immunodefic Rev. 1989;1(2):105-33. [Medline].

30. Reid RR, Woodcock S, Prodeus AP, Austen J, Kobzik L, Hechtman H, et al. The role of complement receptors CD21/CD35 in positive selection of B-1 cells. Curr Top Microbiol Immunol. 2000;252:57-65. [Medline].

31. Rhein LM, Perkins M, Gerard NP, Gerard C. FcgammaRIII is protective against Pseudomonas aeruginosa pneumonia. Am J Respir Cell Mol Biol. Apr 2008;38(4):401-6. [Medline].

32. Rigal D, Andreoni C, Vermot-Desroches C, Rousset F, Souillet G, Robert J. [Physiopathological roles of leukocyte adhesion proteins: LFA-1, CR3, P150-95 in man]. Pediatrie. 1988;43(3):185-90. [Medline].

33. Smiley JD, Moore SE Jr. Immune-complex vasculitis: role of complement and IgG-Fc receptor functions. Am J Med Sci. Oct 1989;298(4):267-77. [Medline].

34. Tedder TF, Poe JC, Fujimoto M, Haas KM, Sato S. The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system. Curr Dir Autoimmun. 2005;8:55-90. [Medline].

35. Webb J, Whaley K. Complement and immune complex diseases. Aust N Z J Med. Apr 1986;16(2):268-78. [Medline].

36. Whaley K, Schwaeble W. Complement and complement deficiencies. Semin Liver Dis. 1997;17(4):297-310. [Medline].

37. Wilson JG, Ratnoff WD, Schur PH, Fearon DT. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus. Arthritis Rheum. Jun 1986;29(6):739-47. [Medline].

Further Reading

Keywords

C3 receptor deficiency, CR1 or CD35 deficiency, CR2 or CD21 deficiency, CR3 deficiency, CR4 deficiency, leukocyte adhesion deficiency, C3a and C5a receptor deficiency

Contributor Information and Disclosures

Author

Robert A Schwartz, MD, MPH, Professor and Head of Dermatology, Professor of Medicine, Professor of Pediatrics, Professor of Pathology, Professor of Preventive Medicine and Community Health, UMDNJ-New Jersey Medical School
Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American College of Physicians, and Sigma Xi
Disclosure: Nothing to disclose.

Coauthor(s)

Isabelle Thomas, MD, Associate Professor, Department of Dermatology, University of Medicine and Dentistry of New Jersey, New Jersey Medical School; Chief of Dermatology Service, Veterans Affairs Medical Center of East Orange
Isabelle Thomas, MD is a member of the following medical societies: American Academy of Dermatology and Sigma Xi
Disclosure: Nothing to disclose.

Medical Editor

Evan R Farmer, MD, Professor of Dermatology, Johns Hopkins University School of Medicine, Clinical Professor of Pathology, Virginia Commonwealth University School of Medicine; Consulting Staff, Department of Dermatology, Johns Hopkins Hospital, VCU Health Services
Evan R Farmer, MD is a member of the following medical societies: American Academy of Dermatology, American Dermatological Association, American Medical Association, American Society of Dermatopathology, and International Society of Dermatology
Disclosure: Nothing to disclose.

Pharmacy Editor

David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Director, Division of Dermatology, Scott and White Clinic; Director Dermatology Residency Training Program, Scott and White Clinic
David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa
Disclosure: 3M Pharmaceutical Grant/research funds Other; Graceway Pharmaceuticals Grant/research funds Other

Managing Editor

Jeffrey P Callen, MD, Professor of Medicine, Chief, Division of Dermatology, University of Louisville School of Medicine
Jeffrey P Callen, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American College of Physicians, and American College of Rheumatology
Disclosure: Amgen Honoraria Consulting; Abbott Honoraria Consulting; Electrical Optical Sciences Honoraria Consulting; Centocor Honoraria Consulting

CME Editor

Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University
Catherine Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.